Acute interstitial nephritis secondary to deferasirox causing acute renal injury needing short-term dialysis

Nephrology

Volumn 15, Issue 3, 2010, Pages 377-

  Yew, Cheong T ^a   Talaulikar, Girish S ^a   Falk, Michael C ^a   Clayton, Phillip ^a   DRozario, James ^a   Brown, Michael ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEFERASIROX; PREDNISOLONE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; IRON OVERLOAD; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MULTIPLE MYELOMA; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REMISSION; RENAL REPLACEMENT THERAPY; SHORT COURSE THERAPY; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE;

AGED; BENZOIC ACIDS; BIOPSY; GLUCOCORTICOIDS; HUMANS; IRON CHELATING AGENTS; KIDNEY FAILURE, ACUTE; MALE; NEPHRITIS, INTERSTITIAL; PREDNISOLONE; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 77950492450     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01183.x     Document Type: Article

References (4)

1. Neufilend EJ. Oral chelators Deferasirox and deferiprone for transfusional iron overload in thalassaemia major: New data, questions. Blood 2006 107 : 3436 3441.
2. Kontoghiorghes GJ. Deferasirox: Uncertain future following renal failure fatalities, agranulocytosis and other toxicities. Expert Opin Drug Saf 2008 6 : 235 239.
3. Food and Drug Administration. Deferasirox (marketed as ex-jade). Drug Safety Newsletter Report, Volume 1, Number 1, Fall 2007.
4. Brosnahan G, Gokden N, Swaminathan S. Acute interstitial nephritis due to deferasirox: A case report. Nephrol. Dial. Transplant. 2008 23 : 3356 3358.